Intestinal Barrier Dysfunction: A Novel Therapeutic Target for Inflammatory Response in Acute Stanford Type A Aortic Dissection

Conclusions: Intestinal barrier dysfunction, reflected by an increased level of serum DAO, may play an important role in the development of systemic inflammatory responses in patients with ATAAD. Therefore, strategies of preserving a normal intestinal barrier function may open new horizons in the treatment of inflammation-related adverse events in the setting of ATAAD.

http://cpt.sagepub.com/cgi/content/abstract/21/1/64?rss=1

Source: Journal of Cardiovascular Pharmacology and Therapeutics - December 10, 2015 Category: Cardiology Authors: Gu, J., Hu, J., Qian, H., Shi, Y., Zhang, E., Guo, Y., Xiao, Z., Fang, Z., Zhong, M., Zhang, H., Meng, W. Tags: Clinical Studies Source Type: research